NextGen Healthcare Unveils New Innovations During HIMSS12; Solutions Foster Collaborative Care and Patient Engagement
Market-leading EHR, Population Management, Business Intelligence, Digital Pen and Mobile Services Empower Providers to Advance Community Connectivity and Improve Quality of Care
HORSHAM, Pa. (February 21, 2012) – NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and leading provider of healthcare information systems and connectivity solutions, today unveiled several new innovations that drive collaborative care and patient engagement during the 2012 HIMSS Annual Conference and Exhibition in Las Vegas.
NextGen Healthcare’s comprehensive suite of products and services span the continuum of care to support emerging initiatives such as Accountable Care Organizations, Patient-Centered Medical Home and Health Information Exchange. To this end, the new products and enhancements to view at NextGen Healthcare’s HIMSS12 booth #2023 include:
- Market-leading EHR. The market-leading EHR is based upon more than 20 years of clinical experience and input from thousands of clinical users. The redesigned system boasts automated outcomes reporting, enhanced disease management workflows and content for more than 25 specialties. A new user interface, standardized framework for all templates and streamlined navigation make the latest version of NextGen
- NextCare(TM) Patient Population Management. NextCare integrates with NextGen Ambulatory EHR and NextGen
- NextGen Healthcare’s Performance Management Suite. The Performance Management Suite provides sophisticated self-service analytics. This suite of flexible tools helps healthcare organizations meet reporting needs for regulatory, clinical and financial key performance indicators.
- NextPen(TM) is an innovative digital pen device that quickly and accurately captures structured patient data directly from an English or foreign language form and then transfers the information to the NextGen Ambulatory EHR. This eliminates scanning and transcription costs while improving operation efficiency. NextPen, which utilizes Anoto technology, also stores data from hundreds of forms without running out of space.
NextGen Healthcare’s comprehensive suite of products and services span the continuum of care to support emerging initiatives such as Accountable Care Organizations, Patient-Centered Medical Home and Health Information Exchange.
“These innovations are offering providers new ways to deliver care, manage costs and maximize outcomes, Scott Decker, president of NextGen Healthcare. “Today’s digital age affords us more intelligence and improved approaches to healthcare. At NextGen Healthcare, we are continually finding and developing ground-breaking ways to deliver more efficient, higher quality care today, helping to propel the industry forward and from which the entire provider and patient community can benefit.”
About NextGen Healthcare
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen or Facebook at http://www.facebook.com/NextGenHealthcare.
This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company’s future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company’s ability or inability to attract and retain qualified personnel; possible regulation of the Company’s software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods’ financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems’ periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company’s quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company’s revenues and operating results are very difficult to forecast. A major portion of the Company’s costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company’s period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
Source: NextGen Healthcare